Fortrea Holdings Inc. (FTRE)
Health Care / Biotechnology
S&P SmallCap 600$9.49
Scores poorly across most models. Proceed with caution.
Weak
Score based on 4 of 5 models — moderate confidence
Is Fortrea Holdings Inc. a Good Investment in 2026?
Fortrea Holdings Inc. (FTRE) scores 3.6 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating Fortrea Holdings Inc. as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 95%). Fortrea Holdings Inc. ranks #922 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
3/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 95%)
Frequently Asked Questions
Is Fortrea Holdings Inc. (FTRE) a good investment?
What is Fortrea Holdings Inc.'s Piotroski F-Score?
Is FTRE overvalued or undervalued?
How does FTRE compare to other Health Care stocks?
What do investment models say about FTRE?
Similar Stocks
Compare FTRE with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer